News & insights

Covid-19

Counterfeit Christmas

Christmas is a counterfeiter’s high season, and with UK e-commerce expected to be worth almost GBP200 billion at the end of 2020 it is likely this year’s festive period will provide even more opportun...

Covid-19

How is COVID-19 changing patent practice?

We have all had to adapt in the past few months, as we have become used to widespread lockdowns, home working and reliance on technology rather than face-to-face contact.

Covid-19

AI in Drug Repurposing

To solve the greatest challenges, it often makes sense to turn to the most advanced technology. In healthcare, the present challenge has never been greater: how to combat the coronavirus pandemic.

Covid-19

Second medical uses at the EPO

The COVID-19 pandemic has highlighted the importance of investigating the use of known medications for the treatment of new diseases.

Covid-19

The worldwide pharma response to coronavirus – Part 2: Promising leads

Rapid spread of the novel coronavirus, SARS-CoV-2, presents an enormous challenge for the global community.

Covid-19

How the engineering industry is aiding the fight against COVID-19

New technologies continually define and guide responses across the globe to the new challenges at hand. They ultimately save lives by enhancing our ability to harness resources in original and efficie...

Covid-19

European Patents just outside of their 9 month Opposition Period can still be Opposed under the EPO COVID-19 extensions

It is common-place to await the end of the EPO 9 month Opposition period before using any recently granted EP patent in an enforcement, letter before action or negotiation regarding the monopoly right...

Covid-19

EPO calls time on most face-to-face hearings in favour of videoconferences

Prompted by the coronavirus pandemic, the European Patent Office (EPO) has announced a significant change to the way it will hold hearings – known as ‘oral proceedings’ – moving forward.

Covid-19

Will COVID-19 alter the IP systems indefinitely?

The current world-wide restrictions on travel have potentially monumental impact on the administration of legal systems.

Covid-19

A note from Gwilym Roberts, Chair

We like to say we understand what our clients are going through, but never has it been truer than now! Coronavirus (or COVID-19) has flipped everyone’s worlds upside down, creating a driving need for ...

Covid-19

COVID-19: The worldwide pharma response to coronavirus disease

As expected in these life-threatening times, the pharma companies respond by doing what they do best: research and development.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept